COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
Title : MVA-based virotherapies in the treatment of infectious diseases
Genevieve Inchauspe, ImmunResQ Department, France
Title : Phage therapy in clinical practice: Experience in chronic bone infections
Alfonso Recordare, Dell'Angelo Hospital, Italy
Title : Essential functions of RNA virus genome beyond the storage of protein-coding information
Alfredo Berzal-Herranz, Instituto de Parasitologia y Biomedicina “Lopez-Neyra”, (IPBLN) CSIC, Spain
Title : The rationale of ethanol inhalation for disinfection of the respiratory tract in SARS-CoV-2-positive asymptomatic subjects
Pietro Salvatori, Private Practice, Italy
Title : Rapid, isothermal detection of Zika virus: a potential alternative to RT-PCR
Rickyle Christopher Balea, The University of the Sunshine Coast, Australia
Title : Comparisons of the molnupiravir, sotrovimab, and remdesivir use for COVID-19 patients in a tertiary hospital of Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan